2011
DOI: 10.1016/j.rhum.2010.08.013
|View full text |Cite
|
Sign up to set email alerts
|

Corrélations entre les scores cliniques, radiographique et échographiques d’enthésite au cours de la spondylarthrite ankylosante

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 27 publications
0
3
0
Order By: Relevance
“…The diagnosis of enthesitis is both an essential element for the positive diagnosis and a parameter for the evaluation of the disease activity. 32 Several indices have been proposed for the evaluation of enthesitis activity, the MASES, LEI and SPARCC scores. MASES remains the most used index because, in addition to its good metrological properties, it takes into account the major peripheral and axial entheseal sites affected by SpA.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The diagnosis of enthesitis is both an essential element for the positive diagnosis and a parameter for the evaluation of the disease activity. 32 Several indices have been proposed for the evaluation of enthesitis activity, the MASES, LEI and SPARCC scores. MASES remains the most used index because, in addition to its good metrological properties, it takes into account the major peripheral and axial entheseal sites affected by SpA.…”
Section: Resultsmentioning
confidence: 99%
“…MASES remains the most used index because, in addition to its good metrological properties, it takes into account the major peripheral and axial entheseal sites affected by SpA. 32 Ultrasound coupled with Doppler remains the examination of choice to confirm both the diagnosis and follow the evolution of enthesitis. 32 …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Its prevalence in the general population has been estimated around 2-7 % [6], but is higher in patients with chronic rheumatic diseases such as axSpA, where it's estimated between 14-16% [8], ranging from 11.1% (6.0-16.2%) to 20.3% (6.5-34.1%) according to axSpA sub-classification [9]. This prevalence is similar when compared to other chronic rheumatic diseases [10][11][12][13].…”
Section: Introductionmentioning
confidence: 84%